Applications for the MASCC Risk Index for Febrile Neutropenia in Patients with Hematologic Malignancy

被引：0
|
作者：
O'Neal, Richard [1 ]
Roberts, Kandice [2 ]
Chen, Quan [2 ]
Huang, Bin [2 ]
Saeed, Hayder [3 ]
Ramlal, Reshma [3 ]
Monohan, Gregory [3 ]
Hildebrandt, Gerhard C. [3 ]
机构：
[1] Univ Kentucky, Hematol & Oncol, Lexington, KY USA
[2] Univ Kentucky, Lexington, KY USA
[3] Univ Kentucky, Markey Canc Ctr, Hematol & Blood & Marrow Transplant, Lexington, KY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
177
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas
    Xiao Jun Wang
    Denise Yun Ting Goh
    Sreemanee Raaj Dorajoo
    Alexandre Chan
    Supportive Care in Cancer, 2017, 25 : 2815 - 2822
  • [32] Infective endocarditis is rare in patients with hematologic malignancy and neutropenia
    Scolarici, Michael J.
    Berman, Leigh R.
    Callander, Natalie
    Smith, Jeannina
    Saddler, Christopher
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (03)
  • [33] Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
    Monuszko, Karen A.
    Albright, Benjamin
    De Oca, Mary Katherine Montes
    Nguyen Thao Thi Nguyen
    Havrilesky, Laura J.
    Davidson, Brittany A.
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [34] Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy
    Hiromi Nishi
    Kouji Ohta
    Yuri Kuramoto
    Hideo Shigeishi
    Taiji Obayashi
    Yukio Yoshioka
    Masaru Konishi
    Shuichi Munenaga
    Hisao Nagoshi
    Tetsumi Yoshida
    Noriyasu Fukushima
    Naoya Kakimoto
    Hiroki Ohge
    Hidemi Kurihara
    Tatsuo Ichinohe
    Hiroyuki Kawaguchi
    Scientific Reports, 12
  • [35] Periodontal inflamed surface area in oral cavity associated with febrile neutropenia in patients with hematologic malignancy undergoing chemotherapy
    Nishi, Hiromi
    Ohta, Kouji
    Kuramoto, Yuri
    Shigeishi, Hideo
    Obayashi, Taiji
    Yoshioka, Yukio
    Konishi, Masaru
    Munenaga, Shuichi
    Nagoshi, Hisao
    Yoshida, Tetsumi
    Fukushima, Noriyasu
    Kakimoto, Naoya
    Ohge, Hiroki
    Kurihara, Hidemi
    Ichinohe, Tatsuo
    Kawaguchi, Hiroyuki
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] The risk factors for febrile neutropenia during chemotherapy in children with malignancy
    Sulviani, Rini
    Idjradinata, Ponpon
    Raspati, Harry
    PAEDIATRICA INDONESIANA, 2007, 47 (02) : 83 - 87
  • [37] Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy
    Nakagawa, Yasunori
    Suzuki, Kenshi
    Masaoka, Toru
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (03) : 174 - 179
  • [38] Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies
    Stohs, Erica J.
    Abbas, Anum
    Freifeld, Alison
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (02)
  • [39] Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice
    Kumar, P.
    Bajpai, J.
    Shetty, N.
    Medekar, A.
    Kurkure, P. A.
    Ghadyalpatil, N.
    Gupta, S.
    Noronha, V
    Kanujia, A.
    Parikh, P.
    Banavali, S. D.
    INDIAN JOURNAL OF CANCER, 2014, 51 (04) : 491 - U370
  • [40] FACTORS AFFECTING THE OUTCOME OF FEBRILE NEUTROPENIA IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    Zawam, H.
    Edesa, W.
    Salama, R.
    Gaber, M.
    Sherief, M.
    Naseef, C.
    Ezzat, N.
    HAEMATOLOGICA, 2015, 100 : 475 - 475
12345